{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:46:17Z","timestamp":1764510377851},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.canlet.2009.11.017","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T09:22:42Z","timestamp":1262164962000},"page":"133-139","source":"Crossref","is-referenced-by-count":19,"title":["p21Cip1 Confers resistance to imatinib in human chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"292","author":[{"given":"Nuria","family":"Ferrandiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Albajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Teresa Gomez-Casares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen E.","family":"Lopez-Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dolores Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.11.017_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2009.11.017_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/366707a0","article-title":"Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit","volume":"366","author":"Gu","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.11.017_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","article-title":"p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest","volume":"76","author":"Dulic","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2009.11.017_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.11.017_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/377552a0","article-title":"Radiation-induced cell cycle arrest compromised by p21 deficiency","volume":"377","author":"Brugarolas","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.11.017_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90039-X","article-title":"Mice lacking p21CIP1\/WAF1 undergo normal development, but are defective in G1 checkpoint control","volume":"82","author":"Deng","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2009.11.017_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/sj.onc.1209972","article-title":"Genetic dissection of the role of p21Cip1\/Waf1 in p53-mediated tumour suppression","volume":"26","author":"Efeyan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.11.017_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0962-8924(02)00043-0","article-title":"New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?","volume":"13","author":"Coqueret","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2009.11.017_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4161\/cc.3.7.971","article-title":"Induction of transcription by p21Waf1\/Cip1\/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs","volume":"3","author":"Poole","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2009.11.017_bib10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1101\/gad.341405","article-title":"p21WAF1\/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation","volume":"19","author":"Devgan","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2009.11.017_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1535-6108(03)00308-8","article-title":"p21Waf1\/Cip1 as a therapeutic target in breast and other cancers","volume":"4","author":"Weiss","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2009.11.017_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/cc.6.4.3855","article-title":"The multiple battles fought by anti-apoptotic p21","volume":"6","author":"Janicke","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2009.11.017_bib13","first-page":"639","article-title":"The role of the cyclin-dependent kinase inhibitor p21 in apoptosis","volume":"1","author":"Gartel","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2009.11.017_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dnarep.2008.12.001","article-title":"HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53","volume":"8","author":"Ferrandiz","year":"2009","journal-title":"DNA Repair"},{"key":"10.1016\/j.canlet.2009.11.017_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nature Rev."},{"key":"10.1016\/j.canlet.2009.11.017_bib16","first-page":"6234","article-title":"Tumor susceptibility of p21(Waf1\/Cip1)-deficient mice","volume":"61","author":"Martin-Caballero","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.11.017_bib17","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1038\/sj.onc.1202840","article-title":"Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis","volume":"18","author":"Philipp","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.11.017_bib18","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1038\/sj.onc.1207994","article-title":"Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon","volume":"23","author":"Poole","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.11.017_bib19","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1073\/pnas.96.16.9089","article-title":"p21(WAF1\/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential","volume":"96","author":"Topley","year":"1999","journal-title":"Proc Nat. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2009.11.017_bib20","first-page":"3021","article-title":"p21Cip1 nullizygosity increases tumor metastasis in irradiated mice","volume":"63","author":"Jackson","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.11.017_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug","volume":"1","author":"Capdeville","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2009.11.017_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(02)00025-9","article-title":"Perspectives on the development of a molecularly targeted agent","volume":"1","author":"Druker","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2009.11.017_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","article-title":"Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR-ABL tyrosine kinase, CGP 57148","volume":"5","author":"Dan","year":"1998","journal-title":"Cell Death Diff."},{"key":"10.1016\/j.canlet.2009.11.017_bib24","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2009.11.017_bib25","first-page":"241","article-title":"C-myc expression in cell lines derived from chronic myeloid leukemia","volume":"89","author":"Gomez-Casares","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2009.11.017_bib26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.leu.2402309","article-title":"Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype","volume":"15","author":"Keeshan","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2009.11.017_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00277-007-0400-9","article-title":"Role of p21(WAF1\/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells","volume":"87","author":"Forster","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canlet.2009.11.017_bib28","first-page":"447","article-title":"Establishment of a Ph1-positive human cell line (BV173)","volume":"70","author":"Pegoraro","year":"1983","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.canlet.2009.11.017_bib29","first-page":"3603","article-title":"Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase","volume":"53","author":"Beran","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.11.017_bib30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood.V66.6.1384.1384","article-title":"Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome","volume":"66","author":"Ogura","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2009.11.017_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ijc.2910190119","article-title":"Properties of the K562 cell line derived from a patient with chronic myeloid leukemia","volume":"19","author":"Lozzio","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2009.11.017_bib32","doi-asserted-by":"crossref","first-page":"18120","DOI":"10.1074\/jbc.M500758200","article-title":"p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells","volume":"280","author":"Munoz-Alonso","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.11.017_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.canlet.2008.05.024","article-title":"PU.1 expression is restored upon treatment of chronic myeloid leukemia patients","volume":"270","author":"Albajar","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2009.11.017_bib34","doi-asserted-by":"crossref","first-page":"32813","DOI":"10.1074\/jbc.M313656200","article-title":"Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells","volume":"279","author":"Ajenjo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.11.017_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/MCB.18.1.629","article-title":"Effects of p21(Cip1\/Waf1) at both the G1\/S and the G2\/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication","volume":"18","author":"Niculescu","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2009.11.017_bib36","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.leu.2403106","article-title":"Constitutive cytoplasmic localization of p21(Waf1\/Cip1) affects the apoptotic process in monocytic leukaemia","volume":"17","author":"Schepers","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2009.11.017_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2141.2003.04538.x","article-title":"Bcr-Abl upregulates cytosolic p21WAF-1\/CIP-1 by a phosphoinositide-3-kinase (PI3K)-independent pathway","volume":"123","author":"Keeshan","year":"2003","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.canlet.2009.11.017_bib38","series-title":"G1 Phase Progression","first-page":"1","article-title":"G1 phase control and cell differentiation","author":"Munoz-Alonso","year":"2003"},{"key":"10.1016\/j.canlet.2009.11.017_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.canlet.2009.11.017_bib40","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.onc.1203541","article-title":"c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells","volume":"19","author":"Ceballos","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.11.017_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/excr.1998.4319","article-title":"Transcriptional regulation of the p21(WAF1\/CIP1) gene","volume":"246","author":"Gartel","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2009.11.017_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2004.02.018","article-title":"Flt3 mutation activates p21WAF1\/CIP1 gene expression through the action of STAT5","volume":"316","author":"Takahashi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2009.11.017_bib43","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Shuai","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2009.11.017_bib44","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood.V94.3.1108.415k07_1108_1112","article-title":"STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells","volume":"94","author":"de Groot","year":"1999","journal-title":"Blood"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509006879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509006879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T10:12:38Z","timestamp":1590487958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509006879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0304383509006879"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.11.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}